A clinical trial investigating acute rectal administration of SCFA mixtures, containing physiological amounts of butyrate (and acetate and propionate), also did not show an increase in fasting and postprandial circulating GLP-1 concentrations compared to placebo in men with overweight/obesity (53). This evidence concerns the gene GCG and obesity due to melanocortin 4 receptor deficiency.